{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:15:34Z","timestamp":1776323734416,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canrad.2022.06.007","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T12:33:50Z","timestamp":1661517230000},"page":"931-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer de l\u2019endom\u00e8tre de stade localis\u00e9\u00a0: la perspective d\u2019une d\u00e9sescalade th\u00e9rapeutique guid\u00e9e par la classification mol\u00e9culaire"],"prefix":"10.1016","volume":"26","author":[{"given":"S.","family":"Espenel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Genestie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Durdux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Haie-Meder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.06.007_bib0165","unstructured":"World Health Organization. GLOBOCAN 2020: estimated cancer incidence, mortality and prevalence worldwide in 2020. Available: http:\/\/gco. iarc. fr\/today\/data\/factsheets\/cancers\/24- Corpus- uteri- fact- sheet. pdf [Accessed 28\u00a0May 2022]. n.d."},{"key":"10.1016\/j.canrad.2022.06.007_bib0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0175","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0180","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1\u00a0endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.007_bib0185","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5\u00a0randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC\/E.N. 5\u00a0Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.007_bib0195","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2022.06.007_bib0200","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.007_bib0205","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.007_bib0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canrad.2022.06.007_bib0215","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","article-title":"Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2\u00a0Trial","volume":"93","author":"de Boer","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.007_bib0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0225","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1111\/IGC.0b013e3181f5c688","article-title":"A role for adjuvant radiation in clinically early carcinoma of the endometrium?","volume":"20","author":"Thomas","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0230","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2014.322","article-title":"Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians","volume":"111","author":"Kunneman","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/gyno.2002.6825","article-title":"Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?","volume":"87","author":"Cohn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"Guntupalli","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0245","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ejso.2007.01.009","article-title":"Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study","volume":"33","author":"Gemer","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0250","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1\u00a0and 2\u00a0trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0255","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0260","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2022.06.007_bib0265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/jnci\/dju402","article-title":"Prognostic significance of POLE proofreading mutations in endometrial cancer","volume":"107","author":"Church","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2022.06.007_bib0270","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of \u201cmultiple-classifier\u201d endometrial carcinomas","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0275","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.ejca.2014.07.014","article-title":"L1\u00a0cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results","volume":"50","author":"Bosse","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0280","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2\u00a0trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0285","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ijgc-2020-001929","article-title":"PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer","volume":"30","author":"van den Heerik","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2022.06.007_bib0290","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.2017.2068","article-title":"Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial","volume":"317","author":"Janda","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2022.06.007_bib0295","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/JCO.2011.38.8645","article-title":"Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2\u00a0Study","volume":"30","author":"Walker","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0300","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0305","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2019.03.103","article-title":"Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer","volume":"153","author":"Rozenholc","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0310","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S1470-2045(18)30448-0","article-title":"Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial","volume":"19","author":"Frumovitz","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0315","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.19.02381","article-title":"Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203\u00a0Study","volume":"38","author":"Yeung","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.007_bib0160","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:35:34Z","timestamp":1761136534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1278321822001081"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.007","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer de l\u2019endom\u00e8tre de stade localis\u00e9\u00a0: la perspective d\u2019une d\u00e9sescalade th\u00e9rapeutique guid\u00e9e par la classification mol\u00e9culaire","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}